Regulation 7 Notification of decisions

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

reg. 7(1)(a)(vi) words substituted by National Health Service (Pharmaceutical Services) 2004 reg. 6
reg 7 am (W) by National Health Service (Pharmaceutical Services) Regulation 2009 reg 6
reg. 7 words substituted by National Health Service Reform and Health Care Professions Act 2002 (Supplementary, Consequential etc. Provisions) 2002 reg. 13 Sch. 10
reg. 7 8 words substituted by National Health Service (Local Pharmaceutical Services Etc.) 2002 reg. 15 Sch.
reg. 7(1)(a)(iia) inserted by National Health Service (Local Pharmaceutical Services Etc.) 2002 reg. 8(a)
reg. 7(1)(d) and word inserted by National Health Service (Local Pharmaceutical Services Etc.) 2002 reg. 8(b)

(1)

An FHSA shall, as soon as practicable, give notice in writing of its decision on an application under regulation 4(2), or of its decision whether or not to amend the premises named in the original application as mentioned in regulation 4(10), to—

(a)

in the case of an application to which regulation 4(3) or (10) applies—

(i)

the applicant,

(ii)

any person who is included in a pharmaceutical list and whose interests might, in the opinion of the FHSA, be significantly affected by the decision,

(iii)

the Local Pharmaceutical Committee,

(iv)

the Local Medical Committee,

(v)

any FHSA any part of whose locality is within two kilometres of the premises, and

(vi)

any Community Health Council serving the locality of the FHSA or of any other FHSA notified under regulation 5(1)(d); and

(b)

in the case of an application to which regulation 4(4) applies—

(i)

the applicant, and

(ii)

any person who has made representations to the FHSA in accordance with regulation 5(1) or (2),

and shall include with the notice a statement of the reasons for the decision and of any rights of appeal.

(2)

Any FHSA which is notified under sub-paragraph (1)(a)(v) shall, as soon as practicable, give notice in writing of the decision and reasons to—

(a)

the Local Pharmaceutical Committee for its locality;

(b)

the Local Medical Committee for its locality; and

(c)

any person whose name is included in the pharmaceutical list and whose interests might in the opinion of that Authority be significantly affected by the decision;

and shall notify them of any rights of appeal arising under regulation 8.